Last edition
News about "Microsatellite instability-high "
Vividion Initiates Phase 2 Trial of VVD-214 in Advanced Colorectal Cancer
Vividion Therapeutics doses the first patient in a Phase 2 trial evaluating VVD-214 in combination with pembrolizumab for advanced colorectal cancer.
Microsatellite Instability-high | 16/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members